Big Pharma

Oregon Bill Would Boost Market Access To Generic Prescription Drugs 

This article is for premium subscribers. Please sign up here for a tax-deductible subscription. 

If you're a premium subscriber, sign in below. 

Senate Bill 764 would prevent "pay to delay" agreements between pharmaceutical companies that delay the introduction of generic prescription drugs into the market.

Subscribe to Big Pharma